Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $322.83 million. The enterprise value is $261.60 million.
| Market Cap | 322.83M |
| Enterprise Value | 261.60M |
Important Dates
The last earnings date was Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 47.90 million shares outstanding. The number of shares has increased by 1,394.00% in one year.
| Shares Outstanding | 47.90M |
| Shares Change (YoY) | +1,394.00% |
| Shares Change (QoQ) | +1,314.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,181.25 |
| Forward PS | n/a |
| PB Ratio | 3.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,767.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.38, with a Debt / Equity ratio of 0.72.
| Current Ratio | 9.38 |
| Quick Ratio | 9.18 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $1,574 |
| Profits Per Employee | -$728,521 |
| Employee Count | 94 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.89 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.57 |
| Average Volume (30 Days) | 253,734 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Fractyl Health had revenue of $148,000 and -$68.48 million in losses. Loss per share was -$1.43.
| Revenue | 148,000 |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | -68.48M |
| EBITDA | n/a |
| EBIT | n/a |
| Loss Per Share | -$1.43 |
Balance Sheet
The company has $121.76 million in cash and $60.53 million in debt, giving a net cash position of $61.22 million or $1.28 per share.
| Cash & Cash Equivalents | 121.76M |
| Total Debt | 60.53M |
| Net Cash | 61.22M |
| Net Cash Per Share | $1.28 |
| Equity / Book Value | 84.18M |
| Book Value Per Share | 1.76 |
| Working Capital | 111.20M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | -46,270.95% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,394.00% |
| Shareholder Yield | -1,394.00% |
| Earnings Yield | -21.21% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Fractyl Health is $18.00, which is 167.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.00 |
| Price Target Difference | 167.06% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |